These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 18388958)

  • 1. Intravitreal bevacizumab for macular edema secondary to retinal macroaneurysm.
    Chanana B; Azad RV
    Eye (Lond); 2009 Feb; 23(2):493-4. PubMed ID: 18388958
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term effect of intravitreal bevacizumab (avastin) in patients with chronic diffuse diabetic macular edema.
    Kook D; Wolf A; Kreutzer T; Neubauer A; Strauss R; Ulbig M; Kampik A; Haritoglou C
    Retina; 2008 Oct; 28(8):1053-60. PubMed ID: 18779710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Avastin a treatment of diabetic macular edema].
    Stan C; Sevan S; Mureşan I
    Oftalmologia; 2011; 55(1):63-7. PubMed ID: 21774389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bevacizumab and retinal ischemia.
    Neubauer AS; Kook D; Haritoglou C; Priglinger SG; Kampik A; Ulbig MW; Ceklic L
    Ophthalmology; 2007 Nov; 114(11):2096. PubMed ID: 17980746
    [No Abstract]   [Full Text] [Related]  

  • 5. Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema.
    Haritoglou C; Kook D; Neubauer A; Wolf A; Priglinger S; Strauss R; Gandorfer A; Ulbig M; Kampik A
    Retina; 2006; 26(9):999-1005. PubMed ID: 17151486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of intravitreal bevacizumab (IVB) in treating macular edema secondary to branch retinal vein occlusion (BRVO).
    Wong I; Koo S; Chan C
    Retina; 2010 Apr; 30(4):710; author reply 710-1. PubMed ID: 20386100
    [No Abstract]   [Full Text] [Related]  

  • 7. Intravitreal bevacizumab for diabetic macular edema associated with severe capillary loss: one-year results of a pilot study.
    Bonini-Filho M; Costa RA; Calucci D; Jorge R; Melo LA; Scott IU
    Am J Ophthalmol; 2009 Jun; 147(6):1022-30, 1030.e1-5. PubMed ID: 19327746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravitreal bevacizumab for macular oedema secondary to branch retinal vein occlusion: more data required.
    Hu K; Horgan SE; Sivaraj RR; Avgikos K
    Eye (Lond); 2010 Jan; 24(1):194; author reply 194-5. PubMed ID: 19218984
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparative therapy evaluation of intravitreal bevacizumab and triamcinolone acetonide on persistent diffuse diabetic macular edema.
    Kumar V; Ghosh B; Raina UK; Goel N
    Am J Ophthalmol; 2008 Dec; 146(6):974; author reply 974-5. PubMed ID: 19027427
    [No Abstract]   [Full Text] [Related]  

  • 10. The article by Kook et al 1 on the 1-year effect of bevacizumab in patients with chronic diffuse diabetic macular edema (DME).
    Querques G
    Retina; 2009 May; 29(5):718-9; author reply 719-20. PubMed ID: 19430285
    [No Abstract]   [Full Text] [Related]  

  • 11. Diffuse diabetic macular oedema treated with intravitreal bevacizumab or triamcinolone acetonide.
    Rensch F; Spandau UH; Wickenhäuser A; Jonas JB
    Acta Ophthalmol; 2010 Mar; 88(2):e36-7. PubMed ID: 19210330
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of unilateral intravitreal bevacizumab (avastin), in the treatment of diffuse bilateral diabetic macular edema: a pilot study.
    Velez-Montoya R; Fromow-Guerra J; Burgos O; Landers MB; Morales-Catón V; Quiroz-Mercado H
    Retina; 2009 Jan; 29(1):20-6. PubMed ID: 18784623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravitreal bevacizumab for the treatment of refractory diabetic macular edema.
    Mehta S; Blinder KJ; Shah GK; Kymes SM; Schlief SL; Grand MG
    Ophthalmic Surg Lasers Imaging; 2010; 41(3):323-9. PubMed ID: 20507016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiogenic and inflammatory markers in the intraocular fluid of eyes with diabetic macular edema and influence of therapy with bevacizumab.
    Funk M; Schmidinger G; Maar N; Bolz M; Benesch T; Zlabinger GJ; Schmidt-Erfurth UM
    Retina; 2010 Oct; 30(9):1412-9. PubMed ID: 20711086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary intravitreal bevacizumab (Avastin) for diabetic macular edema: results from the Pan-American Collaborative Retina Study Group at 6-month follow-up.
    Arevalo JF; Fromow-Guerra J; Quiroz-Mercado H; Sanchez JG; Wu L; Maia M; Berrocal MH; Solis-Vivanco A; Farah ME;
    Ophthalmology; 2007 Apr; 114(4):743-50. PubMed ID: 17398322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the effect of intravitreal bevacizumab injection on diabetic macular edema after cataract surgery.
    Takamura Y; Kubo E; Akagi Y
    Ophthalmology; 2009 Jun; 116(6):1151-7. PubMed ID: 19376589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of macular ischemia on the outcome of intravitreal bevacizumab therapy for diabetic macular edema.
    Chung EJ; Roh MI; Kwon OW; Koh HJ
    Retina; 2008; 28(7):957-63. PubMed ID: 18698297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravitreal bevacizumab for macular edema due to occlusive vasculitis.
    Margolis R; Lowder CY; Sears JE; Kaiser PK
    Semin Ophthalmol; 2007; 22(2):105-8. PubMed ID: 17564933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retinal sensitivity after intravitreal injection of bevacizumab for the treatment of macular edema secondary to retinal vein occlusion.
    Yamaike N; Tsujikawa A; Sakamoto A; Ota M; Kotera Y; Miyamoto K; Kita M; Yoshimura N
    Retina; 2009 Jun; 29(6):757-67. PubMed ID: 19289982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative therapy evaluation of intravitreal bevacizumab and triamcinolone acetonide on persistent diffuse diabetic macular edema.
    Shimura M; Nakazawa T; Yasuda K; Shiono T; Iida T; Sakamoto T; Nishida K
    Am J Ophthalmol; 2008 May; 145(5):854-61. PubMed ID: 18328456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.